Carmen and Ann Adams Department of Pediatrics, Wayne State University, Children's Hospital of Michigan, 3901 Beaubien St, Detroit, MI 48201, USA.
Pediatrics. 2010 Nov;126(5):887-93. doi: 10.1542/peds.2009-3059. Epub 2010 Oct 25.
Prevalence estimates of illicit drug use by teens are typically generated from confidential or anonymous self-report. While data comparing teen self-report with biological measures are limited, adult studies identify varying degrees of under-reporting.
Hair analyses for cocaine, opiates and marijuana were compared to confidential teen self- and parent-reported teen drug use in a longitudinal cohort of >400 high-risk urban teens and parents.
Both teens and parents substantially underreported recent teen cocaine and opiate use. However, compared with parents, teens were more likely to deny biomarker-verified cocaine use. Teen specimens (hair) were 52 times more likely to identify cocaine use compared with self-report. Parent hair analyses for cocaine and opiate use were 6.5 times and 5.5 times, respectively, more likely to indicate drug use than were parental self-report. The lack of concordance between self-report and bioassay occurred despite participant's knowledge that a "certificate of confidentiality" protected both teen and adult participants, and that the biological specimens would be tested for drugs.
These findings confirm prior reports of adult under-reporting of their own drug use while extending our understanding of teen's self-admitted drug use. The lack of concordance between teen self- or parent-reported teen drug use and biomarkers confirm our concerns that both teen- and parent-reported teen drug use is limited, at least for youth in high-risk urban settings. Methods of ascertainment other than self- or parent-report must be considered when health care providers, researchers and public health agencies attempt to estimate teen drug-use prevalence.
青少年非法药物使用的流行率估计通常是通过机密或匿名的自我报告得出的。虽然比较青少年自我报告与生物标志物的数据有限,但成人研究发现存在不同程度的漏报。
对可卡因、阿片类药物和大麻的毛发分析与纵向队列中 >400 名高危城市青少年及其父母的机密青少年自我报告和父母报告的青少年药物使用进行了比较。
青少年和父母都大大低估了最近青少年可卡因和阿片类药物的使用。然而,与父母相比,青少年更有可能否认经生物标志物验证的可卡因使用。青少年样本(头发)比自我报告更有可能识别可卡因使用,其可能性是自我报告的 52 倍。与父母自我报告相比,父母的可卡因和阿片类药物毛发分析分别更有可能表明存在药物使用,其可能性分别是父母自我报告的 6.5 倍和 5.5 倍。尽管参与者知道“保密证书”保护青少年和成年参与者,并且生物样本将被检测药物,但自我报告和生物测定之间缺乏一致性。
这些发现证实了先前关于成年人对自己药物使用的漏报报告,同时扩展了我们对青少年自我承认的药物使用的理解。青少年自我报告或父母报告的青少年药物使用与生物标志物之间缺乏一致性,这证实了我们的担忧,即青少年和父母报告的青少年药物使用至少在高风险城市环境中的青少年中是有限的。当医疗保健提供者、研究人员和公共卫生机构试图估计青少年药物使用的流行率时,必须考虑除自我报告或父母报告之外的其他确定方法。